Stay updated on Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedAdded a consolidated Locations section listing trial sites by state (Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Florida, Georgia, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, New York, North Carolina, Ohio, Oklahoma, Oregon, Texas, Utah, Washington, Wisconsin, Wyoming) and a revision note (v3.3.3). This change replaces multiple individual state location subsections, altering how site availability is displayed to users.SummaryDifference0.9%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedAdded Banner North Colorado Medical Center - Loveland Campus and updated the Nat Med article citation with authors. Removed Banner McKee Medical Center.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision: v3.3.2 replaces v3.3.1 on the page.SummaryDifference0.0%

- Check44 days agoChange DetectedPublication section wording updated to indicate PubMed publications are automatically filled from PubMed, and the revision tag was updated to v3.3.1 (the corresponding deletions note updated to v3.2.0).SummaryDifference0.0%

- Check51 days agoChange DetectedRemoval of the government funding/operating status notice. The page's study details and trial information remain unchanged.SummaryDifference0.1%

- Check66 days agoChange DetectedDifference0.1%

Stay in the know with updates to Pembrolizumab for Desmoplastic Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab for Desmoplastic Melanoma Clinical Trial page.